• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

乳腺导管原位癌中基质金属蛋白酶及其组织抑制剂的研究

Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.

作者信息

Gonzalez L O, Corte M D, Vazquez J, Junquera S, Sanchez R, Viña A, Rodriguez J C, Lamelas M L, Vizoso F

机构信息

Unidad de Investigación, Hospital de Jove, Gijón, Spain.

出版信息

Histopathology. 2008 Oct;53(4):403-15. doi: 10.1111/j.1365-2559.2008.03136.x.

DOI:10.1111/j.1365-2559.2008.03136.x
PMID:18983606
Abstract

AIMS

To analyse the expression of metalloproteinases (MMPs) and their inhibitors (TIMPs) in ductal carcinoma in situ of the breast (DCIS).

METHODS AND RESULTS

An immunohistochemical study was performed in 56 patients with pure DCIS, in 39 with DCIS adjacent to invasive carcinoma (IDC) and 63 patients with T1 IDC, using tissue microarrays and specific antibodies against MMPs and TIMPs. Immunohistochemical results were categorized using a specific software program. The data were analysed by unsupervised hierarchical cluster analysis by each cellular type. IDC showed a higher expression rate of MMP-7 and TIMP-1 than pure DCIS, as well as a higher expression rate of MMP-9 and TIMP-3 than the DCIS component of mixed cases, whereas pure DCIS showed a higher rate of expression of MMP-9 and -11 and TIMP-3 than in the DCIS component of mixed cases. Pure DCIS with a periductal inflammatory infiltrate showed significantly higher MMP-2, -14 and TIMP-1. Dendograms identified two cluster groups with distinct MMP/TIMP expression profiles in neoplastic cells and fibroblastic or mononuclear inflammatory cells surrounding the neoplastic ducts of pure DCIS.

CONCLUSIONS

The results indicate the distinct variability in MMP/TIMP expression by DCIS, which may be of potential biological and clinical interest in breast cancer.

摘要

目的

分析金属蛋白酶(MMPs)及其抑制剂(TIMPs)在乳腺导管原位癌(DCIS)中的表达情况。

方法与结果

采用组织芯片以及针对MMPs和TIMPs的特异性抗体,对56例单纯DCIS患者、39例伴有浸润性癌(IDC)的DCIS患者以及63例T1期IDC患者进行免疫组化研究。使用特定软件程序对免疫组化结果进行分类。通过对每种细胞类型进行无监督层次聚类分析来分析数据。IDC显示出比单纯DCIS更高的MMP-7和TIMP-1表达率,以及比混合病例中的DCIS成分更高的MMP-9和TIMP-3表达率,而单纯DCIS显示出比混合病例中的DCIS成分更高的MMP-9和-11以及TIMP-3表达率。伴有导管周围炎性浸润的单纯DCIS显示出显著更高的MMP-2、-14和TIMP-1。树形图在单纯DCIS肿瘤导管周围的肿瘤细胞和成纤维细胞或单核炎性细胞中识别出两个具有不同MMP/TIMP表达谱的聚类组。

结论

结果表明DCIS在MMP/TIMP表达方面存在明显差异,这可能在乳腺癌中具有潜在的生物学和临床意义。

相似文献

1
Study of matrix metalloproteinases and their tissue inhibitors in ductal in situ carcinomas of the breast.乳腺导管原位癌中基质金属蛋白酶及其组织抑制剂的研究
Histopathology. 2008 Oct;53(4):403-15. doi: 10.1111/j.1365-2559.2008.03136.x.
2
Immunohistochemical study of matrix metalloproteinases and their inhibitors in pure and mixed invasive and in situ ductal carcinomas of the breast.乳腺单纯及混合浸润性原位导管癌中基质金属蛋白酶及其抑制剂的免疫组化研究。
Hum Pathol. 2010 Jul;41(7):980-9. doi: 10.1016/j.humpath.2009.08.027. Epub 2010 Mar 17.
3
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.乳腺导管原位癌中肿瘤细胞和基质细胞金属蛋白酶及其抑制剂的表达及其与微浸润事件的关系。
J Cancer Res Clin Oncol. 2010 Sep;136(9):1313-21. doi: 10.1007/s00432-010-0782-2. Epub 2010 Feb 3.
4
Comparative analysis and clinical value of the expression of metalloproteases and their inhibitors by intratumor stromal fibroblasts and those at the invasive front of breast carcinomas.肿瘤内基质成纤维细胞与乳腺癌浸润前沿的金属蛋白酶及其抑制剂表达的比较分析与临床价值
Breast Cancer Res Treat. 2009 Jul;116(1):39-52. doi: 10.1007/s10549-009-0351-z. Epub 2009 Feb 25.
5
Expression of cytokeratin markers, ER-alpha, PR, HER-2/neu, and EGFR in pure ductal carcinoma in situ (DCIS) and DCIS with co-existing invasive ductal carcinoma (IDC) of the breast.细胞角蛋白标志物、雌激素受体α(ER-α)、孕激素受体(PR)、人表皮生长因子受体2/neu(HER-2/neu)和表皮生长因子受体(EGFR)在乳腺单纯导管原位癌(DCIS)及合并浸润性导管癌(IDC)的DCIS中的表达。
Ann Clin Lab Sci. 2007 Spring;37(2):127-34.
6
Study of matrix metalloproteinases and their inhibitors in breast cancer.乳腺癌中基质金属蛋白酶及其抑制剂的研究。
Br J Cancer. 2007 Mar 26;96(6):903-11. doi: 10.1038/sj.bjc.6603666. Epub 2007 Mar 6.
7
Expression and prognostic significance of matrix metalloproteinases and their tissue inhibitors in primary neuroendocrine carcinoma of the skin.基质金属蛋白酶及其组织抑制剂在原发性皮肤神经内分泌癌中的表达及预后意义
Hum Pathol. 2003 Jan;34(1):80-8. doi: 10.1053/hupa.2003.51.
8
Overexpression of matrix metalloproteinases and their inhibitors in mononuclear inflammatory cells in breast cancer correlates with metastasis-relapse.基质金属蛋白酶及其抑制剂在乳腺癌单核炎性细胞中的过表达与转移复发相关。
Br J Cancer. 2007 Oct 8;97(7):957-63. doi: 10.1038/sj.bjc.6603963. Epub 2007 Sep 11.
9
Collagenase-3 expression in breast myofibroblasts as a molecular marker of transition of ductal carcinoma in situ lesions to invasive ductal carcinomas.乳腺肌成纤维细胞中胶原酶-3的表达作为导管原位癌病变向浸润性导管癌转变的分子标志物。
Cancer Res. 2001 Oct 1;61(19):7091-100.
10
Evidence that molecular changes in cells occur before morphological alterations during the progression of breast ductal carcinoma.有证据表明,在乳腺导管癌进展过程中,细胞的分子变化先于形态学改变出现。
Breast Cancer Res. 2008;10(5):R87. doi: 10.1186/bcr2157. Epub 2008 Oct 17.

引用本文的文献

1
From ductal carcinoma in situ to invasive breast cancer: the prognostic value of the extracellular microenvironment.从导管原位癌到浸润性乳腺癌:细胞外微环境的预后价值
J Exp Clin Cancer Res. 2024 Dec 23;43(1):329. doi: 10.1186/s13046-024-03236-z.
2
Plasma Levels of Metalloproteinase 3 (MMP-3) and Metalloproteinase 7 (MMP-7) as New Candidates for Tumor Biomarkers in Diagnostic of Breast Cancer Patients.血浆中基质金属蛋白酶3(MMP - 3)和基质金属蛋白酶7(MMP - 7)水平作为乳腺癌患者诊断中肿瘤生物标志物的新候选指标
J Clin Med. 2023 Mar 30;12(7):2618. doi: 10.3390/jcm12072618.
3
Importance of Altered Gene Expression of Metalloproteinases 2, 9, and 16 in Acute Myeloid Leukemia: Preliminary Study.
金属蛋白酶2、9和16基因表达改变在急性髓系白血病中的重要性:初步研究
J Oncol. 2021 May 6;2021:6697975. doi: 10.1155/2021/6697975. eCollection 2021.
4
MMP1 and MMP11 Expression in Peripheral Blood Mononuclear Cells upon Their Interaction with Breast Cancer Cells and Fibroblasts.基质金属蛋白酶 1 和基质金属蛋白酶 11 在与乳腺癌细胞和成纤维细胞相互作用时在外周血单个核细胞中的表达。
Int J Mol Sci. 2020 Dec 31;22(1):371. doi: 10.3390/ijms22010371.
5
Tumour progression and metastasis.肿瘤进展与转移
Ecancermedicalscience. 2016 Jan 29;10:617. doi: 10.3332/ecancer.2016.617. eCollection 2016.
6
Low microvascular density at the tumor center is related to the expression of metalloproteases and their inhibitors and with the occurrence of distant metastasis in breast carcinomas.肿瘤中心的低微血管密度与金属蛋白酶及其抑制剂的表达有关,并与乳腺癌的远处转移发生有关。
Int J Clin Oncol. 2013 Aug;18(4):629-40. doi: 10.1007/s10147-012-0428-2. Epub 2012 Jun 12.
7
Duodenal expression of Toll-like receptors and interleukins are increased in both children and adult celiac patients.十二指肠 Toll 样受体和白细胞介素的表达在儿童和成人乳糜泻患者中均增加。
Dig Dis Sci. 2012 Sep;57(9):2278-85. doi: 10.1007/s10620-012-2184-6. Epub 2012 May 6.
8
Expression of metalloproteases and their inhibitors by tumor and stromal cells in ductal carcinoma in situ of the breast and their relationship with microinvasive events.乳腺导管原位癌中肿瘤细胞和基质细胞金属蛋白酶及其抑制剂的表达及其与微浸润事件的关系。
J Cancer Res Clin Oncol. 2010 Sep;136(9):1313-21. doi: 10.1007/s00432-010-0782-2. Epub 2010 Feb 3.
9
Expression of metalloproteases and their inhibitors in different histological types of breast cancer.不同组织学类型乳腺癌中金属蛋白酶及其抑制剂的表达。
J Cancer Res Clin Oncol. 2010 Jun;136(6):811-9. doi: 10.1007/s00432-009-0721-2. Epub 2009 Nov 15.